168 related articles for article (PubMed ID: 24980264)
1. Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.
Saito K; Maekawa K; Ishikawa M; Senoo Y; Urata M; Murayama M; Nakatsu N; Yamada H; Saito Y
Toxicol Sci; 2014 Oct; 141(2):377-86. PubMed ID: 24980264
[TBL] [Abstract][Full Text] [Related]
2. UPLC-MS-based serum metabonomics for identifying acute liver injury biomarkers in Chinese miniature pigs.
Ma J; Yu J; Su X; Zhu C; Yang X; Sun H; Chen D; Wang Y; Cao H; Lu J
Toxicol Lett; 2014 Mar; 225(3):358-66. PubMed ID: 24451218
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling of lysophosphatidylcholines in chlorpromazine hydrochloride- and
Hu C; Li HW; Ke JQ; Yu XC; Zhao MY; Shi XY; Wu LJ; Tang XL; Xiong YH
Hum Exp Toxicol; 2022; 41():9603271221108320. PubMed ID: 35722787
[TBL] [Abstract][Full Text] [Related]
4. Identification of Lysophosphatidylcholines and Sphingolipids as Potential Biomarkers for Acute Aortic Dissection via Serum Metabolomics.
Zhou X; Wang R; Zhang T; Liu F; Zhang W; Wang G; Gu G; Han Q; Xu D; Yao C; Guo D; Fu W; Qi Y; Wang L
Eur J Vasc Endovasc Surg; 2019 Mar; 57(3):434-441. PubMed ID: 30087010
[TBL] [Abstract][Full Text] [Related]
5. Plasma sphingolipids: potential biomarkers for severe hepatic fibrosis in chronic hepatitis C.
Li JF; Qu F; Zheng SJ; Ren F; Wu HL; Liu M; Ren JY; Chen Y; Duan ZP; Zhang JL
Mol Med Rep; 2015 Jul; 12(1):323-30. PubMed ID: 25695872
[TBL] [Abstract][Full Text] [Related]
6. Arachidonic acid-containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen-induced hepatic phospholipidosis.
Saito K; Goda K; Kobayashi A; Yamada N; Maekawa K; Saito Y; Sugai S
J Appl Toxicol; 2017 Aug; 37(8):943-953. PubMed ID: 28138993
[TBL] [Abstract][Full Text] [Related]
7. A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis.
García-Cañaveras JC; Peris-Díaz MD; Alcoriza-Balaguer MI; Cerdán-Calero M; Donato MT; Lahoz A
Electrophoresis; 2017 Sep; 38(18):2331-2340. PubMed ID: 28512733
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents.
Luo L; Schomaker S; Houle C; Aubrecht J; Colangelo JL
Toxicol Sci; 2014 Jan; 137(1):12-25. PubMed ID: 24085190
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics study with gas chromatography-mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine.
Lee MS; Jung BH; Chung BC; Cho SH; Kim KY; Kwon OS; Nugraha B; Lee YJ
Int J Toxicol; 2009; 28(5):392-404. PubMed ID: 19605889
[TBL] [Abstract][Full Text] [Related]
10. Qualified method for the estimation of di-18:1 bis(monoacylglycero)phosphate in urine, a noninvasive biomarker to monitor drug-induced phospholipidosis.
Murali BV; Kurawattimath V; Bhutani P; Onorato J; Naikodi SB; Kole P; Rajanna PK
Bioanalysis; 2020 Aug; 12(15):1049-1059. PubMed ID: 32735140
[No Abstract] [Full Text] [Related]
11. Gene expression profiling in rat liver treated with compounds inducing phospholipidosis.
Hirode M; Ono A; Miyagishima T; Nagao T; Ohno Y; Urushidani T
Toxicol Appl Pharmacol; 2008 Jun; 229(3):290-9. PubMed ID: 18355885
[TBL] [Abstract][Full Text] [Related]
12. Increased serum bile acid concentration following low-dose chronic administration of thioacetamide in rats, as evidenced by metabolomic analysis.
Jeong ES; Kim G; Shin HJ; Park SM; Oh JH; Kim YB; Moon KS; Choi HK; Jeong J; Shin JG; Kim DH
Toxicol Appl Pharmacol; 2015 Oct; 288(2):213-22. PubMed ID: 26222700
[TBL] [Abstract][Full Text] [Related]
13. Ketoconazole-induced hepatic phospholipidosis in the mouse and its association with de-N-acetyl ketoconazole.
Whitehouse LW; Menzies A; Mueller R; Pontefract R
Toxicology; 1994; 94(1-3):81-95. PubMed ID: 7801332
[TBL] [Abstract][Full Text] [Related]
14. Plasma Lipidomics Reveals Insights into Anti-Obesity Effect of
Shon JC; Kim WC; Ryu R; Wu Z; Seo JS; Choi MS; Liu KH
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003339
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice.
Li S; Liu H; Jin Y; Lin S; Cai Z; Jiang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2369-75. PubMed ID: 21763219
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of metabolic and elemental markers in methamphetamine-induced hepatic injury to rats using LC-MS/MS and ICP-MS.
Zhang Y; Li L; Wang Q; Shen M; Han W; Yang X; Chen L; Ma A; Zhou Z
Anal Bioanal Chem; 2019 Jun; 411(15):3361-3372. PubMed ID: 31119349
[TBL] [Abstract][Full Text] [Related]
17. Intraalveolar foam cells associated with lipidosis-like alterations in lung and liver of rats treated with tricyclic psychotropic drugs.
Lüllmann-Rauch R; Scheid D
Virchows Arch B Cell Pathol; 1975 Nov; 19(3):255-68. PubMed ID: 174284
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice.
Asaoka Y; Togashi Y; Imura N; Sai T; Miyoshi T; Miyamoto Y
Exp Toxicol Pathol; 2013 Sep; 65(6):817-23. PubMed ID: 23276623
[TBL] [Abstract][Full Text] [Related]
19. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.
Kumar BS; Chung BC; Kwon OS; Jung BH
J Appl Toxicol; 2012 Jul; 32(7):505-20. PubMed ID: 22131085
[TBL] [Abstract][Full Text] [Related]
20. Integrated plasma and urine metabolomics coupled with HPLC/QTOF-MS and chemometric analysis on potential biomarkers in liver injury and hepatoprotective effects of Er-Zhi-Wan.
Yao W; Gu H; Zhu J; Barding G; Cheng H; Bao B; Zhang L; Ding A; Li W
Anal Bioanal Chem; 2014 Nov; 406(28):7367-78. PubMed ID: 25245419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
